Evidence map›Paper›PMID 35058348›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.

Hannah W Despres, Margaret G Mills, David J Shirley, Madaline M Schmidt, Meei-Li Huang, Pavitra Roychoudhury, Keith R Jerome, Alexander L Greninger, Emily A Bruce

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. SARS-CoV-2 viral load and shedding kinetics.Nature reviews. Microbiology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Viral infectivity in pediatric SARS-CoV-2 clinical samples does not vary by age.medRxiv : the preprint server for health sciences · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Hannah W DespresDepartment of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405.ORCID 0000-0003-0321-5202
Margaret G MillsVirology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98105.ORCID 0000-0002-0493-9408
David J ShirleyData Science Department, Faraday, Inc., Burlington, VT 05405.
Madaline M SchmidtDepartment of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405.
Meei-Li HuangVirology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98105.ORCID 0000-0002-2861-8035
Pavitra RoychoudhuryVirology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98105.ORCID 0000-0002-4567-8232
Keith R JeromeVirology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98105.
Alexander L GreningerVirology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98105.
Emily A BruceDepartment of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405; Emily.bruce@med.uvm.edu.ORCID 0000-0001-8391-370X

Funding

Using Dengue Controlled Human Infection Model to Identify Adaptive Immune Correlates of ProtectionP20GM125498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Ellen Kozelka · 2018 to 2026
$24.9M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
NIGMS NIH HHS P20 GM125498NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants pose a challenge to controlling the COVID-19 pandemic. Previous studies indicate that clinical samples collected from individuals infected with the Delta variant may contain higher levels of RNA than previous variants, but the relationship between levels of viral RNA and infectious virus for individual variants is unknown. We measured infectious viral titer (using a microfocus-forming assay) and total and subgenomic viral RNA levels (using RT-PCR) in a set of 162 clinical samples containing SARS-CoV-2 Alpha, Delta, and Epsilon variants that were collected in identical swab kits from outpatient test sites and processed soon after collection. We observed a high degree of variation in the relationship between viral titers and RNA levels. Despite this, the overall infectivity differed among the three variants. Both Delta and Epsilon had significantly higher infectivity than Alpha, as measured by the number of infectious units per quantity of viral E gene RNA (5.9- and 3.0-fold increase;

Indexed as

Gene Expression Regulation, ViralGenome, ViralAnimalsCell Line, TumorChlorocebus aethiopsCoronavirus Envelope ProteinsCOVID-19HepatocytesHumansRNA, ViralSARS-CoV-2Vero CellsViral LoadVirulenceCoronavirus Envelope Proteinsenvelope protein, SARS-CoV-2RNA, ViralDeltainfectivitySARS-CoV-2variantviral load

Identifiers

PMID35058348
PMCPMC8812544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.